Numelvi Tablets 31.6 mg for Itch relief for Very Large Dogs

NUMELVI is a once-daily tablet that serves as a first-line treatment and is the sole second-generation Janus kinase (JAK) inhibitor approved for alleviating pruritus linked to allergic dermatitis, including atopic dermatitis, as well as addressing the clinical signs of atopic dermatitis in dogs. Numelvi represents the next generation of itch relief, providing an innovative solution for managing canine allergic dermatitis with a focus on selectivity, safety, and ease of use. Active Ingredients Numelvi features Atinvicitinib. Indications Designed for the treatment of pruritus associated with allergic dermatitis, including atopic dermatitis, in dogs. For addressing inflammation and clinical symptoms of atopic dermatitis in dogs.
Expires on 28 Feb 2029